Terminology | 2019.12.20
Society for Immunotherapy of Cancer Updates its Clinical Immunotherapy Treatment Guidelines for Advanced Renal Cell Carcinoma
Motivated by the substantial progress in translational and clinical research and improved clinical outcomes seen in recent years, the Society for Immunotherapy of Cancer (SITC) today published updated Cancer Immunotherapy Guidelines for the treatment of patients with advanced renal cell carcinoma.
(PRWeb December 20, 2019)
Read the full story at https://www.prweb.com/releases/society_for_immunotherapy_of_cancer_updates_its_clinical_immunotherapy_treatment_guidelines_for_advanced_renal_cell_carcinoma/prweb16803813.htm
For more information, please visit
https://www.prweb.com/releases/society_f[...]ll_carcinoma/prweb16803813.htm
